Autologous Tumor Infiltrating Lymphocytes( Västra Götaland Region)

N/A

Report date: 2023/06/19 20:00:35

Base Information

Drug NameAutologous Tumor Infiltrating Lymphocytes( Västra Götaland Region)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsUveal melanomaSkin Melanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVästra Götaland Region

China Registration ClassN/A

Develop Information

Active CompaniesVästra Götaland Region

Inactive CompaniesN/A

Active IndicationsUveal melanomaSkin Melanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A